-invasive process, cord blood stem cells offer a powerful and
potentially life-saving resource for treating a growing number of ailments,
including cancer, leukemia, blood, and immune disorders. To find out more
about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our
website at
http://www.corcell.com. For investor information, visit
http://www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
'/>"/>SOURCE Cord Blood America, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials2.
Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes3.
New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA4.
The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes5.
CDC Awards NATT Funding to Improve Blood Clot Awareness6.
FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels7.
Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis8.
Blood Donations in U.S. Testing Positive for Chagas Disease9.
One of Nations Oldest Blood Services Providers Turns to Sysmex America10.
ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood11.
AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test